Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Accounts Payables (2021 - 2025)

Core Scientific (CORZW) has disclosed Accounts Payables for 5 consecutive years, with $126.1 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 554.59% to $126.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $126.1 million through Dec 2025, up 554.59% year-over-year, with the annual reading at $126.1 million for FY2025, 554.59% up from the prior year.
  • Accounts Payables hit $126.1 million in Q4 2025 for Core Scientific, down from $212.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $215.1 million in Q2 2025 to a low of $86179.0 in Q1 2021.
  • Historically, Accounts Payables has averaged $53.6 million across 5 years, with a median of $25.3 million in 2022.
  • Biggest five-year swings in Accounts Payables: skyrocketed 18028.55% in 2022 and later plummeted 87.55% in 2024.
  • Year by year, Accounts Payables stood at $11.6 million in 2021, then skyrocketed by 361.75% to $53.6 million in 2022, then skyrocketed by 188.49% to $154.8 million in 2023, then tumbled by 87.55% to $19.3 million in 2024, then skyrocketed by 554.59% to $126.1 million in 2025.
  • Business Quant data shows Accounts Payables for CORZW at $126.1 million in Q4 2025, $212.2 million in Q3 2025, and $215.1 million in Q2 2025.